AI
IMVT icon

Atom Investors’s Immunovant IMVT Stock Holding History

Atom Investors’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.86M Buy
+74,171
New +$2.26M 0.25% 89
2024
Q1 		– Sell
-5,431
Closed -$229K – 626
2023
Q4 		$229K Buy
+5,431
New +$200K 0.04% 386

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Atom Investors's IMVT Position: Q2 2026 in Review

Atom Investors opened a new position in Immunovant (IMVT) in Q2 2026: 74,171 shares worth $2.86M. The stake represents 0.25% of the portfolio and ranks #89 among its holdings. This is a return to the name: Atom Investors previously reported a position in IMVT as recently as Q4 2023.

Atom Investors first reported a position in IMVT in Q4 2023 and has held it in 2 quarters since. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Atom Investors held 74,171 shares of Immunovant worth $2.86M as of Q2 2026.
  • Immunovant was a new Atom Investors position in Q2 2026.
  • Immunovant made up 0.25% of Atom Investors's portfolio in Q2 2026, its #89 holding.
  • Atom Investors first reported a position in Immunovant in Q4 2023 and has held it in 2 quarters since.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Atom Investors's 13F filing for Q2 2026, filed 14 Aug 2026.